Soligenix, Inc. announced today that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has exercised an option for the evaluation of RiVax®...

Johns Hopkins researchers report that a molecular diagnostic test accurately distinguishes among the three most common causes of vaginitis, an inflammation of vaginal tissue they say accounts for millions...

Researchers have identified mutations in a gene called CARD11 that lead to atopic dermatitis, or eczema, an allergic skin disease. Scientists from the National Institute of Allergy and Infectious Diseases...

The Florida Department of Health in Duval County has confirmed one case of mumps, and the Florida Department of Health in St. Johns County has identified two probable cases of mumps. The three individuals...

Melinta Therapeutics announced Monday that the U.S. Food and Drug Administration (FDA) has approved Baxdela™ (delafloxacin), indicated in adults for the treatment of acute bacterial skin and skin structure...

Pfizer Inc. announced that it has started a Phase 1 trial in healthy volunteers of PF-06760805, an investigational vaccine designed to help protect against Group B Streptococcus (GBS) infection. In newborns,...

NanoBio Corporation today announced the progression of a novel intranasal anthrax vaccine into a pre-clinical IND-enabling toxicology study funded by the U.S. National Institute of Health’s National...

One of the most common insecticides used in the battle against the Aedes aegypti mosquito has no measurable impact when applied in communities where the mosquito has built up resistance to it, a study...

A phase 1 randomized controlled trial has found an Ebola virus disease (EVD) vaccine, developed in Canada, was well-tolerated with no safety concerns, and high antibodies were present in participants...

Data released on the Maine Tracking Network Thursday by Maine Center for Disease Control and Prevention (Maine CDC) reveals that adults over the age of 65 years had the highest rates of Lyme disease in...